Showing results (21-30 of 113) with videos related to
Sort By:
Pageof 12
Plos One|December 16, 2014
High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudyKathrine Meyers, Kristina Rodriguez, Robert W Moeller, et al.AIDS (London, England)|December 20, 2015
Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infectionTeresa H Evering, Allison Applebaum, Melissa La Mar, et al.Mathematical Biosciences|February 10, 2004
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapyMichele Di Mascio, Ruy M Ribeiro, Martin Markowitz, et al.International Immunology|August 19, 2007
Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infectionSandhya Vasan, Michael A Poles, Amir Horowitz, et al.Retrovirology|August 16, 2014
Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelopeTeresa H Evering, Edwin Kamau, Leslie St Bernard, et al.Bulletin of Mathematical Biology|May 17, 2005
Duration of an intermittent episode of viremiaMichele Di Mascio, Jerome K Percus, Ora E Percus, et al.Bulletin of Mathematical Biology|April 5, 2003
The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapyJerome K Percus, Ora E Percus, Martin Markowitz, et al.Journal of Virology|June 28, 2003
Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infectionViviana Simon, Neal Padte, Deya Murray, et al.Journal of Virology|March 29, 2003
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivoMartin Markowitz, Michael Louie, Arlene Hurley, et al.AIDS (London, England)|July 20, 2002
Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individualsViviana Simon, Jeroen Vanderhoeven, Arlene Hurley, et al.Pageof 12